SEARCH

SEARCH BY CITATION

References

  • 1
    Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285:23705.
  • 2
    McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA Jr. Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008; 51:5865.
  • 3
    Barrett TW, Martin AR, Storrow AB, et al. A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillation. Ann Emerg Med. 2011; 57:112.
  • 4
    Stiell IG, Clement CM, Brison RJ, et al. Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments. Ann Emerg Med. 2011; 57:1321.
  • 5
    Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998; 32:695703.
  • 6
    Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction. A systematic review and meta-analysis. Circulation. 2011; 123:158793.
  • 7
    Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011; 306:224854.
  • 8
    Iron K, Zagorski BM, Sykora K, Manuel DG. Living and Dying in Ontario: An Opportunity for Improved Health Information. Institute for Clinical Evaluative Sciences. Available at: www.ices.on.ca/file/living_and_dying_in_ontario_march19-08.pdf. Accessed Nov 12, 2012.
  • 9
    Austin PC, van WC, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011; 49:9329.
  • 10
    Austin PC, Walraven C. The mortality risk score and the ADG score: two points-based scoring systems for the Johns Hopkins aggregated diagnosis groups to predict mortality in a general adult population cohort in Ontario, Canada. Med Care. 2011; 49:9407.
  • 11
    Johns Hopkins University. Johns Hopkins ACG Case-Mix Adjustment System. Available at: http://www.acg.jhsph.edu. Accessed Nov 30, 2012.
  • 12
    Tu JV, Donovan LR, Lee DS, et al. Quality of cardiac care in Ontario: EFFECT Study Phase 1 Report 1. Toronto, ON: Institute for Clinical Evaluative Sciences, 2004.
  • 13
    Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285:286470.
  • 14
    Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010; 137:26372.
  • 15
    Beveridge R, Clarke B, Janes L et al. Implementation guidelines for the Canadian Emergency Department Triage and Acuity Scale (CTAS). Available at: http://caep.ca/sites/default/files/caep/files/ctased16.pdf. Accessed Nov 23, 2012.
  • 16
    Atzema CL, Yun L, Dorian P. Atrial Fibrillation in the Emergency Department: A Population-Based Description. Can J Cardiol 26[Supplement D]. 65D. 2010.
  • 17
    Lee DS, Schull MJ, Alter DA, et al. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail. 2010; 3:22835.
  • 18
    Olsson LG, Swedberg K, Ducharme A et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006;47:19972004.
  • 19
    Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:24350.
  • 20
    World Health Organization. Preventing Chronic Diseases: A Vital Investment: A WHO Global Report. Geneva, Switzerland: The World Health Organization, 2005.